Company / Gross Profit per Share
Collegium Pharmaceutical, Inc. Gross Profit per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$14.61
FY2025
5-year range
$4.48 / $14.61
FY2021-FY2025
Trend
+21.7%
vs FY2024
Sector context
#3 of 29
Health Care
What the data says
Among 29 Health Care companies, Collegium Pharmaceutical, Inc. is in the top 10% for gross profit per share. Gross Profit per Share has increased for 4 consecutive years, from $4.48 in FY2021 to $14.61 in FY2025.
Based on SEC 10-K filings.
14.61 in FY2025 with a 5-year CAGR of +23.0%. Ranks 3rd among 29 companies in Health Care.
Improved from $10.23 to $14.61 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +33.2%
- 5-Year CAGR
- +23.0%
- 10-Year CAGR
- -
Sector benchmark
+82.6% above sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s gross profit per share has grown for 4 consecutive years.
- In FY2025, gross profit per share increased 21.7% year-over-year.
- Ranks #3 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.61 | +21.7% |
| FY2024 | $12.00 | +17.3% |
| FY2023 | $10.23 | +65.4% |
| FY2022 | $6.19 | +38.3% |
| FY2021 | $4.48 | -13.9% |
| FY2020 | $5.20 | +67.7% |
| FY2019 | $3.10 | -11.5% |
| FY2018 | $3.50 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026